AI CAPITAL INTELLIGENCE

Neko Health · Series C · USD 700,000,000 · 2026-07-15

Financing facts, at a glance

Neko Health: financing disclosed on 2026-07-15, Series C, USD 700,000,000. Named investors: Lightspeed Venture Partners, OG Venture Partners, Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.

Original source 1 · Original source 2

Neko Health is recorded in the Industry AI / Healthcare & clinical AI segment. The disclosed financing is Series C, with an amount of USD 700,000,000. Named investors include Lightspeed Venture Partners, OG Venture Partners, Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD.

Disclosed company name
Neko Health
Disclosure date
2026-07-15
Round
Series C
Financing amount
USD 700,000,000
Market coverage
Outside China
Sector
Industry AI / Healthcare & clinical AI
Product form
AI professional services

Disclosed investors

Lightspeed Venture Partners, OG Venture Partners, Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD

Original sources

  1. Source 1 · www.hospitalsandhealthcare.com
  2. Source 2 · techcrunch.com

Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.

Company funding history

Explore this sector

Lightspeed Venture Partners (Chinese)

OG Venture Partners (Chinese)

Atomico (Chinese)

General Catalyst (Chinese)

Lakestar (Chinese)

Liberty City Ventures (Chinese)

Positive Sum (Chinese)

BDT & MSD (Chinese)

All funding records